New disease old vaccine: is recombinant BCG vaccine an answer for COVID-19?

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorGupta, Pramod Kumar-
Data de aceite: dc.date.accessioned2026-02-09T12:15:00Z-
Data de disponibilização: dc.date.available2026-02-09T12:15:00Z-
Data de envio: dc.date.issued2020-08-04-
Data de envio: dc.date.issued2020-08-04-
Data de envio: dc.date.issued2020-10-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/42194-
Fonte completa do material: dc.identifierhttps://www.sciencedirect.com/science/article/pii/S0008874920303476-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1157517-
Descrição: dc.descriptionMycobacterium bovis BCG, a live attenuated tuberculosis vaccine offers protection against disseminated TB in children. BCG exhibits heterologous protective effects against unrelated infections and reduces infant mortality due to non-mycobacterial infections. Recent reports have suggested that BCG vaccination might have protective effects against COVID-19, however it is highly unlikely that BCG vaccine in its current form can offer complete protection against SARS-CoV-2 infection due to the lack of specific immunity. Nonetheless, recombinant BCG strains expressing antigens of SARS-CoV-2 may offer protection against COVID-19 due to the activation of innate as well as specific adaptive immune response. Further proven safety records of BCG in humans, its adjuvant activity and low cost manufacturing makes it a frontrunner in the vaccine development to stop this pandemic. In this review we discuss about the heterologous effects of BCG, induction of trained immunity and its implication in development of a potential vaccine against COVID-19 pandemic.-
Idioma: dc.languageen-
Publicador: dc.publisherElsevier-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceCellular Immunology-
Palavras-chave: dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectBCG vaccine-
Palavras-chave: dc.subjectTrained immunity-
Título: dc.titleNew disease old vaccine: is recombinant BCG vaccine an answer for COVID-19?-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.